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Common lymphoid progenitors (CLPs) are the first bone marrow precursors in which V(D)J 
recombinase activity is up-regulated. Here, we show that loss of the transcription factor 
E47 produces a reduced CLP population that lacks V(D)J recombinase activity and D-J
 
H
 
 
rearrangements in vivo. Apart from a profound arrest before the pro–B cell stage, other 
downstream lymphoid progeny of CLPs are still intact in these mice albeit at reduced numbers. 
In contrast to the inhibition of recombinase activity in early B lineage precursors in E47-
deficient animals, loss of either E47 or its cis-acting target E
 
rag
 
 (enhancer of 
 
rag
 
 transcription) 
has little effect on recombinase activity in thymic T lineage precursors. Taken together, this 
work defines a role for E47 in regulating lineage progression at the CLP stage in vivo and 
describes the first transcription factor required for lineage-specific recombinase activity.
 
Despite the essential role of the V(D)J recombi-
nase in catalyzing antigen receptor loci rearrange-
ment, the molecular mechanisms that regulate
recombinase activity in hematopoietic progen-
itors remain unknown. The 
 
rag1
 
/
 
2
 
 components
of the V(D)J recombinase initiate recombina-
tion by cleaving the DNA at Ig or TCR loci.
 
rag
 
 expression is first detectable in a rare subset
of lin
 
 
 
 
 
sca
 
hi 
 
kit
 
hi
 
 (LSK) progenitors (1). Both 
 
rag
 
transcription and V(D)J recombinase activity are
then up-regulated in bone marrow common
lymphoid progenitors (CLPs), cells that effi-
ciently produce B lymphocytes, and in early
thymic progenitors (ETPs), cells that efficiently
produce T lymphocytes (2, 3).
Conflicting studies highlight a potentially
important role for the E2A gene products E47
and E12 as regulators of V(D)J recombination
during the earliest stages of lymphocyte devel-
opment. First, whole bone marrow from E2A-
or E47-null mice lacks detectable 
 
rag
 
 transcripts
and D-J
 
H
 
 rearrangements, suggesting a require-
ment for E2A activity in IgH recombination
during B cell development (4, 5). However,
both E2A- and E47-null mice also have a
complete block in early B cell production.
Thus, it is unclear whether the lack of 
 
rag
 
expression and D-J
 
H
 
 rearrangements is due to
a specific block in recombination processes or
to the absence of B lineage progenitors. Second,
retroviral reconstitution of E47 in long-term
cultured E2A-deficient hematopoietic progeni-
tors restores both 
 
rag1
 
 and 
 
rag2
 
 expression in
vitro (6), and ectopic expression of E12 in the
70Z/3 cell line promotes expression of 
 
rag1
 
(7). However, in other cell lines, expression of
E2A was not sufficient to initiate V(D)J recombi-
nation in the absence of 
 
rag
 
 cotransfection,
rendering it unclear whether E2A is a major
regulator of 
 
rag
 
 transcription (8–10). Third,
E2A binds to E
 
rag
 
, an enhancer of 
 
rag
 
 expression
whose activity is required for V(D)J recombinase
activity at the CLP stage of development (2,
11). E2A is expressed at low levels in LSKs and
is highly up-regulated during progression to
the B lineage (1, 12), but it remains unknown
whether E2A activity is required for recombi-
nation in CLPs.
E2A initiates a key transcriptional cascade
involving early B cell factor (EBF) and 
 
pax5
 
that leads to the expression of lineage-specific
genes required for B cell development and sur-
vival, including CD19, IgL, mb-1, B29, 
 
 
 
5,
VpreB, and IL7R (13–15). Long-term culture
with IL-7 restores detectable D-J
 
H
 
 joints in
hematopoietic precursors from E2A-null mice,
indicating that these cells can undergo V(D)J
recombination under specific culture condi-
tions (6). There are two possible explanations
for this observation. First, supportive culture
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conditions may enable survival of D-J
 
H
 
 
 
 progenitors that
would have died in vivo due to a developmental block. Sec-
ond, supportive culture conditions may permit recombina-
tion events that are unable to occur in vivo due to the ab-
sence of requisite V(D)J recombination machinery. It would
be useful to identify which hematopoietic progenitor subsets
are still intact in mice lacking E2A gene products to deter-
mine the role of this transcription factor in regulating re-
combination initiation in vivo. To directly address this issue,
we characterized the presence of specific hematopoietic pro-
genitor populations in E47-deficient mice and analyzed re-
combinase activity within these precursor subsets using an in
vivo fluorescent reporter of V(D)J recombinase activity.
 
RESULTS
E47-null mice completely lack pro–B cells
 
Because the precise stage at which B lineage development is
blocked in E47- and E2A-null mice remains undefined, it is
unclear whether the lack of detectable V(D)J rearrangements
in fetal liver and bone marrow (4, 16) is due to a block in re-
combination or to the absence of the relevant developmental
subsets in which V(D)J recombination occurs. Therefore, we
characterized the presence of the earliest B lineage progenitors
in mice lacking E47. AA4.1
 
 
 
 
 
B220
 
 
 
 B lineage progenitors in
the bone marrow can be resolved into pre-pro–B (CD19
 
 
 
CD24
 
lo
 
) and pro-/pre-B (CD19
 
 
 
 
 
CD24
 
hi
 
) subsets (Fig. 1 A,
top and middle rows). For this analysis, we excluded DX5
 
 
 
NK cells, CD4
 
 
 
 DC progenitors, and Ly6C
 
 
 
 myeloid and
plasma cells (2, 17, 18), populations that contribute significant
contamination to the B lineage progenitor gates.
We found that pro–/pre–B cells were virtually undetect-
able in E47-null mice. This population was reduced from
65–82% in E47-heterozygous animals to 0–0.2% in E47-
deficient animals (Fig. 1 A, middle row, and not depicted). In
contrast to the complete absence of pro–B cells, pre-pro–B
cells are detectable in E47-null mice. However, pre-pro–B
cells are reduced three- to fourfold in absolute cell number
from 19,655 
 
 
 
 19,164 (
 
n 
 
 
 
 10) in E47-heterozygous mice to
5,086 
 
 
 
 5,743 (
 
n 
 
 
 
 10) in E47-null mice (Fig. 2). The cy-
tokine receptors flt3 and c-Kit, which are expressed on the
surface of the earliest B lineage precursors and down-regu-
lated thereafter (19, 20), were detectable at comparable levels
on pre-pro–B cells from E47-null versus E47-heterozygous
animals (Fig. 1 B and not depicted).
Because E47 might regulate expression of the AA4.1
epitope, we confirmed the developmental block between
pre-pro– and pro–B cells using an analysis scheme that does
not rely on discrimination of the AA4.1 antigen. Within the
B220
 
 
 
 
 
CD43
 
 
 
 
 
CD4
 
 
 
 
 
DX5
 
 
 
 
 
Ly6C
 
 
 
 
 
IgM
 
 
 
 subset, we found
that CD19
 
 
 
 
 
CD24
 
lo
 
 pre-pro–B cells, but not CD19
 
 
 
 
 
CD24
 
hi
 
pro–B cells, were detectable in E47-null mice (Fig. 1 C,
middle row). Thus, using two different schemes, we found
that E47-deficient animals completely lack the pro- and
pre-B population.
We examined recombinase activity in pre-pro–B cells
from E47-null mice by crossing these animals to the H2-
SVEX recombination substrate reporter line. In these mice,
VEX, a spectral variant of GFP, is a sensitive in vivo reporter
of V(D)J recombinase activity (2, 21). We found that VEX
expression was reduced 65–85% in E47-null pre-pro–B cells
defined according to either phenotypic scheme. The per-
centage of VEX
 
 
 
 pre-pro–B cells in E47-heterozygous ver-
sus E47-null mice was 14 versus 1.5% in AA4.1
 
 
 
 
 
B220
 
 
 
CD19
 
 
 
 
 
CD24
 
lo
 
 pre-pro–B cells (Fig. 1 A, bottom row) and
9.8 versus 1.4% in B220
 
 
 
 
 
CD43
 
 
 
 
 
CD19
 
 
 
 
 
CD24l
 
o
 
 pre-pro–B
cells (Fig. 1 C, bottom row). Thus, E47 is required for V(D)J
recombinase activity at this stage of development.
Taken together, these data show that not only does the B
lineage defect in E47-deficient mice occur earlier than was
previously appreciated, but E47 has two distinct activities in
Figure 1. The B lineage defect in E47-null mice. (A) Bone marrow 
from E47-heterozygous or E47-null mice crossed to the H2-SVEX 
(SB110) background was stained with antibodies to detect CD19  
CD24lo pre-pro–B cells and CD19  CD24hi pro–/pre–B cells within the 
B220  AA4.1  subset. Contaminating populations expressing DX5, 
Ly6C, IgM, or CD4 were excluded from the analysis. Pre-pro–B cells 
were then analyzed for VEX expression. (B) Pre-pro–B cells were examined 
for flt3 expression. (C) B lineage progenitors were identified according 
to an alternative phenotypic model in which CD19  CD24lo pre-pro–B 
cells and CD19  CD24hi pro–B cells are identified within the B220  
CD43  subset. As in A, cells bearing DX5, Ly6C, IgM, or CD4 are excluded 
from the analysis. B cell progenitor populations were subsequently 
analyzed for VEX expression. The data are representative of three to 
five independent experiments. 
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vivo: (a) regulating pre-pro– and pro–B cell development
and (b) controlling V(D)J recombination.
 
E47 and Erag are not required for recombinase activity in T 
lineage progenitors
 
We have previously shown that recombinase activity in B but
not T cells depends on the E
 
rag
 
 enhancer of 
 
rag
 
 expression,
which is a target of E2A (2, 11). In these experiments, we had
examined the effects of E
 
rag 
 
deletion on VEX expression in
splenic T cells, taking advantage of the fact that VEX is a per-
manent marker of V(D)J recombination that occurs in the
thymus (2). To directly assess the contribution of E47 and E
 
rag
 
to V(D)J recombination in thymocytes, we characterized
VEX expression in ETPs from E47- or E
 
rag
 
-null mice.
As shown in Fig. 3 (left), loss of E47 did not significantly
alter VEX expression in early triple negative (TN; CD3
 
 
 
CD4
 
 
 
 
 
CD8
 
 
 
) thymic progenitors, total CD4
 
 
 
 
 
CD8
 
 
 
 double
negative progenitors, or downstream CD4
 
 
 
 
 
CD8
 
 
 
 double
positive progenitor subsets. The most noticeable difference
occurred in the TN1 cells, in which VEX was slightly re-
duced from 71% in E47 wild-type mice versus 54% in E47-
null mice. Consistent with the minimal effect that loss of
E47 has on recombinase activity in early TN subsets, VEX
expression was comparable in ETPs from E47-heterozygous
versus E47-null mice (not depicted). Likewise, E
 
rag
 
 deletion
also had little consequence. VEX expression was virtually
identical or even slightly elevated in TN1–TN4 subsets from
E
 
rag
 
 wild-type versus E
 
rag
 
-null mice (Fig. 3, right).
The minimal effect of E47 on VEX expression in T lin-
eage progenitors cannot be attributed to lack of sensitivity of
the H2-SVEX recombination substrate because VEX ex-
pression completely depends on the presence of 
 
rag1
 
 (Fig.
S1 A, available at http://www.jem.org/cgi/content/full/
jem.20051190/DC1), and recombination efficiency is pro-
portional to levels of 
 
rag
 
 expression (2). Moreover, it is un-
likely that the H2-SVEX transgene is subject to significant
position-dependent effects because VEX is detectable at
comparable levels in hematopoietic tissue from multiple in-
dependent founders (2) and is similar for the earliest TN1–
TN4 populations across two different founders (compare
VEX expression in E47 wild-type H2-SVEX SB110 mice in
Figure 2. Quantification of lymphoid populations in E47-deficient 
animals. E47 wild-type, E47-heterozygous, or E47-null mice were evalu-
ated for the presence of the indicated hematopoietic subsets. Within each 
hematopoietic population, each symbol represents an independent animal. 
See Results for markers used to identify each population. ND, not done; 
NS, not significant. †, P   0.05.
Figure 3. Effects of Erag and E47 on recombinase activity in T lineage 
progenitors. (A) Thymocytes from E47 wild-type, E47-null, Erag wild-type, 
or Erag-null mice crossed to the H2-SVEX (SB110) background were 
stained with antibodies to CD3, CD4, and CD8 to identify immature T cell 
subsets or lineage markers (CD4, CD8 , CD3 ,   -TCR, NK1.1, Mac-1, Gr-1, 
and B220), CD44, and CD25 to identify the earliest T lineage progenitors. 
TN (TN1–TN4) populations are: CD44  CD25  lin , CD44  CD25  lin , 
CD44  CD25  lin , and CD44  CD25  lin , respectively. These populations 
were then analyzed for VEX expression. The data are representative of at 
least two independent experiments.E47 CONTROLS V(D)J RECOMBINATION IN CLPS | Borghesi et al. 1672
Fig. 3 to H2-SVEX SB88 mice in Fig. S1 B). These data are
consistent with the observation that although E47-null thy-
mic progenitors have altered usage of specific TCR V region
genes, these mice do not have a block in TCR recombina-
tion (22). Taken together, these data suggest that both E47
and Erag are required for recombinase expression in early B
cells but not early T cells.
E47 is required for optimal recombinase activity 
in DCs and NK cells
We and others have previously shown that the D-J rearrange-
ments at the IgH locus are not B/T lineage–restricted events
(2, 23), and we wondered if E47 is required for recombination
in other lineages. DC and NK populations have not been
characterized in E47-null mice, and we found that these pop-
ulations are present in reduced numbers. DC precursors in the
bone marrow (AA4.1  CD24lo CD4  B220 ; reference 17)
are reduced approximately fivefold from 64,950   31,239 cells
(n   10) in E47 heterozygotes to 11,818   11,096 (n   10) in
E47-null animals (Fig. 2). Similarly, splenic NK cells (NK1.1 
CD122   CD3 ) are reduced threefold from 450,865  
217,460 (n   5) in E47 heterozygotes to 150,434   83,067
(n   4) from E47-null mice (Fig. 2).
As with pre-pro–B cells, recombinase expression in DC
precursors and NK cells is markedly reduced in the absence of
E47. VEX expression is decreased from 15 to 4.7% in DC
precursors (Fig. 4 A, bottom row) and from 8.9 to 2.8% in
NK cells (Fig. 4 B, bottom row) from E47-heterozygous ver-
sus E47-null mice, respectively. The observation that recom-
binase activity is reduced but not ablated in the absence of E47
highlights the potential contribution of other transcription fac-
tors to regulate recombination at these stages of development.
These data suggest that the requirements for V(D)J re-
combination are coordinately regulated in B cells, NK cells,
and DCs, and are controlled by distinct mechanisms in the T
lineage. This interpretation is consistent with the notion that
B and NK cells as well as some DCs develop from bone
marrow CLPs, whereas the T lineage appears to most effi-
ciently develop from thymic ETPs (24) in which recombina-
tion might be under distinct transcriptional control.
E47 is important for normal development of multipotent 
lymphoid progenitors
rag expression is first detectable in a rare subset of LSK bone
marrow progenitors (1), and recombinase activity is up-reg-
ulated in CLPs (2, 24). Specifically, although rag expression
is detectable in  4% of LSKs (1), 40–50% of CLPs have re-
combination events as measured with the H2-SVEX recom-
bination substrate (2). Therefore, this developmental transi-
tion represents a pivotal stage in dissecting the molecular
requirements for V(D)J recombination initiation.
We quantified LSKs and CLPs in E47-null mice to de-
termine how early in development the E47 defect extends.
Bone marrow LSKs were detected at comparable frequency
(15–22%) in E47 wild-type, E47-heterozygous, and E47-
null mice (Fig. 5 A), suggesting that E47 is not required for
the generation of LSKs. In terms of absolute cell number,
LSKs were somewhat elevated from 56,122   29,989 (n   3)
and 39,530   16,780 (n   9) in E47 wild-type and E47-het-
erozygous mice, respectively, to 73,269   81,328 (n   5) in
E47-null mice (Fig. 2). However, these differences were not
significant (P   0.5). Comparable to rag expression (1), re-
combinase activity is detectable in  1–1.5% of LSKs (not
depicted), and thus, it is difficult to determine whether loss
of E47 affects VEX expression at this stage.
In contrast to LSKs, the CLP population was significantly
reduced in the absence of E47. We identified bone marrow
CLPs using two different phenotypic schemes, again exploit-
ing one staining combination that is independent of the
AA4.1 antigen. As shown in Fig. 5 B (top row), for the first
phenotypic strategy (17), 17–19% of IL7R  lin  cells are
readily detectable as AA4  Scalo bone marrow CLPs in E47
heterozygotes, but this population is reduced to 0.9–9.9% in
E47-null mice shown from three different representative ex-
periments. This 50–95% decrease in the percentage of CLPs
is consistent with a 10-fold reduction in absolute cell num-
ber in this population from 7,556   3,813 (n   6) in E47
wild-type mice and 7,842   2,367 (n   17) in E47-het-
erozygous mice, respectively, to 724   417 in E47 knockout
mice (n   15; Fig. 2). This residual CLP population in E47-
deficient animals also expresses normal levels of c-Kit and
only modestly reduced levels of flt3 (Fig. 5 C).
We confirmed the presence of CLPs in E47-null mice
using the AA4.1-independent definition IL7R  lin  Scalo
c-Kitlo (25). As shown in Fig. 5 D (middle row), these CLPs
Figure 4. Recombinase activity in DCs and NK cells. (A) Bone marrow 
DC precursors (AA4.1  B220  CD4  CD24lo) or (B) splenic NK cells (NK1.1  
CD122  CD19  CD3  CD4  CD8 ) from E47-heterozygous or E47-null mice 
crossed to the H2-SVEX (SB110) background were examined for VEX ex-
pression. The data are representative of two to four independent experiments.JEM VOL. 202, December 19, 2005 1673
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are similarly reduced from 19 to 5.2% in E47-heterozygous
versus E47-null mice. We then confirmed that AA4.1 is de-
tectable on these CLPs. Interestingly, AA4.1 was expressed
on a high percentage of CLPs from E47-null versus E47-
heterozygous mice, but it was reduced fourfold in intensity
(mean fluorescence intensity: 6,245 vs. 1,494 in E47-het-
erozygous vs. E47-null mice; Fig. 5 D, bottom row). It is
unclear whether this decrease in AA4.1 expression reflects a
requirement for E47 for normal levels of expression, or
whether AA4.1hi CLPs represent a developmental stage that
is absent in the E47-deficient animals.
Early lymphoid progenitors are exquisitely sensitive to
apoptosis, and reductions in the CLP compartment could be
due to increases in apoptosis or to a failure to proliferate.
However, we found that  5% of CLPs or pre-pro–B cells
from E47-null animals are annexin V  DAPI  (Fig. 6 A),
consistent with observations that B lymphocyte development
in E47-deficient animals cannot be rescued by a bcl2 transgene
(26). Although frequencies of apoptotic cells were low, dead
pre-pro–B cells (DAPI ) accumulated just over twofold more
in E47-null animals (Fig. 6 A and not depicted), possibly re-
flecting a defect in the ability to clear apoptotic cells. Despite
diminished numbers, CLPs and pre-pro–B cells from E47-
null mice exhibit twofold higher levels of proliferation com-
pared with E47-heterozygous animals. The percentage of
BrdU  progenitors was increased from 20 to 46% in CLPs
and from 37 to 92% in pre-pro–B cells obtained from E47-
heterozygous versus E47-deficient animals (Fig. 6 B). Thus,
Figure 5. Recombinase activity in CLPs. Bone marrow from E47-
heterozygous or E47-null mice was stained with antibodies to detect (A) 
LSKs (lin  Sca-1hi c-Kithi where lineage markers are NK1.1, CD11b, Gr-1, 
TER-119, CD3, CD19, and B220) or (B) CLPs (IL7R  lin  AA4.1  Sca-1lo). Results 
from three independent experiments are shown to provide perspective on 
the scope of the CLP defect across multiple E47-deficient animals. Gates 
were drawn with respect to the relevant controls within each experiment. 
(C) Bone marrow CLPs were then examined for c-Kit and flt3 expression. 
(D) Bone marrow CLPs in E47-heterozygous or E47-null mice were identi-
fied using the following phenotypic scheme that does not rely on the AA4.1 
marker: IL7R  lin  Sca-1lo c-Kitlo. AA4.1 expression is provided for comparison 
to B. The data are representative of 3–10 independent experiments.
Figure 6. Apoptosis and proliferation in multipotent progenitors. 
(A) Bone marrow CLPs and pre-pro–B cells from E47-heterozygous or E47-
knockout mice were stained with annexin V and DAPI to identify live, 
apoptotic, and dead cells. As a positive control for annexin V detection, 
thymocytes from B6 mice were cultured with 1  M dexamethasone for 
5 h to induce apoptosis. (B) Bone marrow from E47-heterozygous or E47-
deficient mice injected with BrdU (shaded histogram) was then stained for 
surface markers to identify CLPs or pre-pro–B cells followed by intracellular 
staining with anti-BrdU antibodies. Background staining (open histogram) 
was determined by injecting E47-heterozygous mice with PBS followed by 
the identical staining procedures. The data are representative of two to 
three independent experiments.E47 CONTROLS V(D)J RECOMBINATION IN CLPS | Borghesi et al. 1674
the reduction in CLPs in E47-null mice is not due to either
increased levels of apoptosis or a block in proliferation.
E47 is indispensable for IgH recombination 
in multipotent CLPs
We examined the role of E47 in regulating recombinase ac-
tivity in AA4.1  Scalo CLPs, an essential step during differ-
entiation to the B lymphocyte lineage. As shown in Fig. 5 B
(bottom row), VEX expression is ablated from 36% in CLPs
from E47-heterozygous mice to 0% in E47-null mice, sug-
gesting that the activity of E47 is absolutely required for re-
combinase activity at this stage of development. The com-
plete loss of recombinase activity is consistent across all three
mice depicted (Fig. 5 B, bottom row), even though these
animals had slightly different percentages of cells detected
within the CLP gate (top row).
Not only did CLPs from E47-deficient mice lack recom-
binase activity, but these progenitors were also deficient in
D-JH recombination events at the endogenous IgH locus (Fig. 7
A). D-JH rearrangements were readily detected in CLPs from
E47-heterozygous animals but were absent or barely discern-
able in CLPs derived from E47-null animals using a highly
sensitive nested PCR strategy. By quantitative single cell PCR
analysis of CLPs, D-JH rearrangements were detectable in 6
out of 26 cells (23%) from E47-heterozygous mice. By con-
trast, of the more than 50 cells examined in E47-null mice,
only one had a D-JH rearrangement (1.9%). Thus, not only are
CLPs reduced 10-fold in terms of absolute number in E47-
null mice, but the frequency of CLPs capable of undergoing
V(D)J recombination is reduced an additional 10-fold.
V(D)J recombination at IgH loci requires rag expression
and Ig gene transcription, and E47 has been shown to regu-
late both processes in cell lines. In primary CLPs, we found
that loss of E47 dramatically inhibits rag expression. Consis-
tent with the 100-fold reduction in recombination-compe-
tent lymphoid progenitors, rag1 was not detectable in CLPs
from E47-deficient animals despite successful amplification
of  -actin transcripts by quantitative RT-PCR (Fig. 7 B). In
contrast to the paucity of rag transcripts,  0 germline tran-
scripts were readily detectable in CLPs from both E47 wild-
type and E47-null mice (the frequency of detecting  0 tran-
scripts in single CLPs was approximately twofold less in
E47-null compared with rag1-deficient mice; not depicted).
Taken together, these data indicate that E47 is required
for rag1 expression and recombinase activity as early as the
CLP stage of development. These results also highlight a
previously unrecognized role for E47 in regulating the de-
velopmental progression of LSKs to multipotent CLPs.
DISCUSSION
The recent definition of a transcriptional hierarchy that con-
trols B lineage development raises fundamental questions
about how E47 promotes B lineage specification in multipo-
tent CLPs. Here, we show that E47 controls B lymphocyte
production through one effect on CLP development and
through a second effect on V(D)J recombination within the
CLPs that do develop. These data provide in vivo evidence
of a role for E47 influencing lineage commitment in multi-
potent hematopoietic progenitors and describe the role of
E47 as the first essential transcriptional regulator of V(D)J re-
combinase activity.
Several studies suggested that E2A genes may regulate rag
activity or other critical steps in V(D)J recombination. E2A
binds to the Erag enhancer (27), and forced expression of
E12 or E47 induces rag transcripts in vitro (6, 7). Moreover,
whole bone marrow and fetal liver from E2A- or E47-null
mice lack detectable rag transcripts and V(D)J recombination
events (4, 5). E2A has also been suggested to play a role in
regulating IgH chromatin structure (28). However, it was
difficult to understand whether E2A gene products control
V(D)J recombination in vivo as E2A- and E47-null mice
have a complete block in the earliest stages of B lym-
phopoiesis. Here, we clearly separate the effects of E47 on
the development of CLPs and pre-pro–B cells versus the ef-
fects of E47 on V(D)J recombination within these subsets. A
Figure 7. Recombination at endogenous IgH loci. (A) Bone marrow 
CLPs as in Fig. 5 D were examined for D-JH rearrangement status at the 
endogenous IgH locus by PCR. Germline (GL) DNA and rearrangements of D 
to J1, J2, J3, or J4 is indicated by arrowheads. Data from two independent sorts 
is shown (E47 heterozygote no. 1 and E47 knockout no. 1, 100 CLPs each; E47 
heterozygote no. 2 and E47 knockout no. 2, 150 CLPs each). Rearrangement 
status of whole bone marrow from wild-type B6 mice and from rag2 knock-
out mice is provided for comparison. Inset depicts the frequency of CLPs that 
have detectable D-JH rearrangements as determined by quantitative single 
cell PCR. (B) rag1 expression was quantified by real-time RT-PCR using 350 
cell equivalents of cDNA from CLPs. Expression of rag1 and the reference 
gene  -actin are shown for equal numbers of CLPs from E47-heterozygous 
and E47 knockout animals.  RN, the fluorescence intensity. Identical results 
were obtained using cells from at least two independent sorts.JEM VOL. 202, December 19, 2005 1675
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diminished CLP subset (defined according to two different
schemes) is detectable in E47-null mice, and this population
lacks rag1 expression, V(D)J recombinase activity, and D-JH
recombination events (Figs. 5 and 7). Similarly, a reduced
pre-pro–B subset is detectable in E47-null mice, and this
population also has significantly reduced levels of recombi-
nase activity (Fig. 1).
Mounting evidence suggests that CLPs are dominantly
early B lineage progenitors rather than T lineage progenitors
(2, 24). Not only are CLPs much more efficient at giving
rise to the B versus T lineage in vivo (29), but our data indi-
cate that V(D)J recombinase activity in CLPs is uniquely
sensitive to loss of either E47 (Fig. 5) or the Erag enhancer
(2). By contrast, ETPs and other T lineage progenitors ap-
pear relatively refractory to E47 or Erag deficiency (Fig. 3
and not depicted). Within the CLP population, the observa-
tion that E47-null mice have a more severe defect in V(D)J
recombinase activity than Erag-null animals (2) suggests that
E47 may regulate rag transcription through Erag-indepen-
dent targets. Erag only is one of several cis-acting elements
that regulate rag (11, 30–32). The D3 enhancer located 8.1
kb upstream of rag2 is of particular interest because D3 con-
trols rag2 expression in B220  bone marrow cells. D3 con-
tains three potential E-box binding sites, but it remains
unknown whether E47 can effectively transactivate this en-
hancer (31).
The lineage-specific activities of E2A might be con-
trolled by at least three distinct mechanisms. First, E2A ac-
tivity is antagonized by direct interaction with Ids, proteins
that lack a DNA binding domain and therefore act as nega-
tive regulators (33, 34). Although relatively little is known
about the patterns of Id expression during the earliest stages
of hematopoiesis, Id1 is detectable as early as the LSK subset
(1), and transgenic mice overexpressing Id1 have significant
reductions in B cell development (34). Second, E2A has dis-
tinct binding partners in the B versus T lineage that may
confer lineage-specific activation potential (35). Third, re-
cent studies tie Notch activity to degradation of E2A protein
(36). This observation is interesting because Notch is a key
player in the B versus T lineage fate decision, with lower
levels of Notch signaling promoting B lymphopoiesis and
higher levels of Notch signaling promoting T lymphopoiesis
(37, 38). Thus, in a simplified model, low signaling through
Notch during progression to the B lineage might be associ-
ated with up-regulation of E2A-dependent rag transcription.
A wealth of evidence supports a role for both Notch- and
Id-dependent regulatory mechanisms at relatively late stages
of hematopoietic development, and it would be useful to
know whether E47, which is detectable at roughly compara-
ble mRNA levels in rag1-GFP  LSKs versus rag1-GFP 
LSKs (1), has differential functional activity at the protein
levels in these subsets.
Our observation that E47 activity is required as early as
the CLP stage of development (Figs. 5 and 7) suggests the
existence of important, but as yet unidentified, B cell–spe-
cific gene targets. The EBF and pax5 transcription factors are
two key regulators of B cell development whose activity de-
pends on E47. However, fetal liver progenitors from EBF-
null mice retain normal percentages of IL7R  c-Kitlo he-
matopoietic progenitors, suggesting that EBF is not essential
for the development of this multipotent population (13).
Likewise, hematopoietic progenitors from pax5-deficient
mice successfully generate D-JH
  pro–B cells, indicating that
the pax5 gene product BSAP is also dispensable in CLPs
(39). It is also interesting to note that CLPs from E47-null
mice have reduced levels of AA4.1 and decreased forward
scatter, consistent with a partial block in CLP development.
The precise function of AA4.1, a lectin-like type I trans-
membrane protein (40), remains unknown, and it will be in-
teresting to determine whether up-regulation of AA4.1 ex-
pression plays a functional role in lineage progression.
Regulation of IgH chromatin structure by E2A (28) could
contribute to lack of V(D)J recombination in E47-deficient
mice. However, E47 may not be essential for establishing
open chromatin at the IgH locus in CLPs as we detected only
a twofold reduction in the frequency of CLPs with germline
 0 transcript. Besides E2A, the related basic helix-loop-helix
family members HEB and E2-2 may also be important for
progression to the B lymphocyte lineage. Mice that are dou-
bly heterozygous for mutations in any two of these three
genes have more profound defects in pro–B cell development
than any single heterozygous mutation (41). HEB and E2-2
are detectable in B lineage progenitors from E47-null mice,
and low-level activity from these genes in concert with EBF is
sufficient to promote reasonably efficient expression of most
B lineage–specific genes (14). The different E proteins, in-
cluding E12, E47, HEB, and E2-2, appear to have different
affinity for E-box consensus sites. Relatively little is known
about the individual roles that each transcription factor plays
during development, although significant redundancies appear
to exist. For example, mice expressing a dominant negative
allele of HEB that forms nonfunctional heterodimers with
E2A show a more pronounced T cell defect than do mice
carrying null mutations for either HEB or E2A alone (35).
Moreover, E2A complexes can be composed of E12 or E47.
E2A is detectable as dominant E47–E12 heterodimers in IL-
7–expanded pro–B cells, whereas mature splenic B cells con-
tain largely E47 homodimers (42). Whether E2A exists func-
tionally as homodimers or heterodimers in LSKs and CLPs,
and whether distinct E protein complexes are can be differen-
tially regulated by Notch- or Id-dependent inhibitory mecha-
nisms, remains to be determined.
Here, we have shown that the activity of E47, a master
regulator of B lineage development, is required for expres-
sion of both rag1 and V(D)J recombinase activity in multipo-
tent hematopoietic progenitors and B lineage lymphocytes.
Distinct factors appear to control recombinase activity in the
T lineage. These data provide one molecular mechanism by
which E47 promotes B lineage specification in vivo. That
additional mechanisms remain to be elucidated is suggested
by our finding that E47-deficient mice fail to generate nor-
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MATERIALS AND METHODS
Mice. H2-SVEX recombination reporter substrate mice were developed
in our laboratory. Two independent H2-SVEX founder lines, SB110 and
SB88, have been extensively characterized elsewhere (2) and are inbred
C57BL/6 mice. Erag- (11) and E47-null mice (43) were crossed to the H2-
SVEX background. All mice were treated humanely in accordance with
federal and state government guidelines, the University of Massachusetts
Medical School institutional animal committee, and the Institutional Ani-
mal Care and Use Committee of the University of Pittsburgh.
Flow cytometry. Freshly isolated bone marrow cells or thymocytes were
resuspended to 3   107/ml in staining media containing biotin-, flavin-, and
phenol red–deficient RPMI 1640 (Irvine Scientific), 10 mM Hepes, pH 7.2,
0.02% sodium azide, 1 mM EDTA, and 3% newborn calf serum, and treated
with 2.4G2 Fc block for 10 min on ice. Cells were incubated with primary an-
tibodies for 20 min and then washed three times, incubated with streptavidin
reagents for 15 min, and then washed three more times. After the final wash,
samples were resuspended in 1  g/ml propidium iodide to exclude dead cells.
VEX was detected using 407 nm excitation (2). Primary antibodies included
thymus AA4.1 biotin or APC; B220 APC or biotin or Cy5PE or FITC; CD3
biotin or Cy5PE; CD4 Cy5PE or PE; CD8  APC or biotin or Cy5PE;
CD11b biotin; CD19 biotin or Cy5PE or FITC; CD24 (clone 30-F1) Alexa
594; Cascade Blue or FITC; CD25 Cy7-APC; CD43 PE; CD122 PE; c-Kit
PE; DX5 biotin or FITC; CD44 FITC;   -TCR biotin; Gr-1 biotin (clone
8C5); IgM (clone 331) biotin or FITC; IL-7R  APC (clone A7R34) or PE
(clone SB/14); Ly6C biotin or FITC; NK1.1 biotin or FITC; TER-119 bi-
otin; and Sca-1 FITC. Secondary reagents were SA-Cy5PE, SA-Alexa 594,
and SA-Cy7PE or SA-APC. Antibodies were purchased from BD Biosciences,
eBioscience, Southern Biotechnology Associates, Inc. or CALTAG. Annexin
V staining was performed according to the manufacturer’s instructions (BD
Biosciences) using 2.5  l annexin V FITC and 0.2  g/ml DAPI per 1.5   105
cells. Flow cytometry was performed on a 3 laser, 7 detector DIVA FACSVan-
tage, a 3 laser, 9 detector LSRII, or a 3 laser, 10 detector FACS Aria (Becton
Dickinson). Data were analyzed with FlowJo software (Tree Star).
BrdU incorporation and annexin staining. For analysis of prolifera-
tion, mice were injected i.p. with 200  g BrdU in PBS, or PBS alone as a
control, at 12-h intervals as described previously (44). 24 h after the first in-
jection, bone marrow was isolated and cells were stained for surface markers
as described above. BrdU detection was performed with the BrdU flow kit
(BD Biosciences) according to the manufacturer’s instructions. For analysis
of apoptosis, bone marrow populations from unmanipulated mice were
stained for surface markers and then incubated with annexin V according to
the manufacturer’s instructions, except that DAPI was used instead of pro-
pidium iodide (BD Biosciences).
DNA isolation and PCR. Genomic DNA was isolated with the QIAGEN
DNeasy kit according to the manufacturer’s instructions. PCR amplification
was performed with 10  l DNA in 25  l total volume with 1.6  M dNTP
(dATP, dTTP, dCTP, and dGTP), 2.5 U Taq, 4 mM MgCl2, 1X Buffer A
(Fisher Scientific), and 4  M of each primer. Primers 2011 (5 ) and 2165 (3 )
were used to detect the presence of the H2-SVEX (2), whereas E47bas for-
ward (5 ) and E47bas reverse (3 ) were used to detect E47 (26) under the
conditions described in each publication. PCR products were visualized with
ethidium bromide on a 1.5% agarose gel in TBE buffer.
Quantitative PCR. Total RNA was prepared from sorted cells using the
RNEasy mini kit (QIAGEN). The cycle conditions for real-time PCR
were 95 C for 12 min followed by 50 cycles at 95 C for 15 s and at 60 C
for 1 min. Probes and primer sets for the rag and actin genes were purchased
from Applied Biosystems. Real-time PCR was performed in duplicate or
triplicate on an ABI Prism 7900HT.
PCR detection of IgH rearrangements. Equal numbers of CLPs from
E47-heterozygous or E47-null mice were sorted directly into Eppendorf
96-well plates containing lysis buffer as described previously (21). The PCR
protocol involves two rounds of amplification with nested primers. In the
first round of PCR, the following three primers were used: GL-5-1,
CCCGGACAGAGCAGGCAGGTGG; DH-5-1, ACAAGCTTCAAAG-
CACAATGCCTGGCT; and DH3-1, AGGCTCTGAGATCCCTAGA-
CAG. In the second round of PCR, two separate reactions were performed
using the following primers: germline detection: GL-5-2, GAGTTGACT-
GAGAGGACAG and GL-3-2, CGAAGTACCAGTAGCAC; and D-JH
rearrangement detection: DH5-2, ACGTCGACTTTT(G or C)TCAAGG-
GATCTACTACTGT and DH3-2, GGGTCTAGACTCTCAGCCG-
GCTCCCTCAGGG. In the first round, PCR amplification was performed
in a total volume of 50  l containing 0.2 mM dNTP, 1  l CLONTECH
Advantage cDNA Polymerase Mix, 1X CLONTECH Advantage PCR
Buffer, 0.5 mg/ml BSA, and 0.4  M of each primer. In the second round, 1
 l of each first-round product was added to a 50- l reaction volume using
the same conditions described above, except that second round primers
were used at 2- M concentrations. The cycling conditions for both rounds
were: 95 C for 1 min, 63 C for 1 min, and 72 C for 1.5 min for 30 cycles,
with a 10-min end extension at 72 C. PCR productions were visualized on
1.5% agarose gels stained with ethidium bromide. For analysis of single cells,
single CLPs were sorted into individual wells and PCR was performed as
described above. Only samples producing either a germline product or a
specific rearrangement product are included in the analysis.
Statistical analysis. A Wilcoxon rank-sum test was used for statistical
comparison of two samples. Multiple comparisons were performed using
the Kruskal-Wallis test with Bonferroni correction of p. Differences were
regarded as significant at P   0.05. Analyses were performed using the JMP
version 5.1 statistical software package (SAS Institute).
Online supplemental material. Fig. S1 shows that VEX expression in T
lineage precursors depends on rag1 and is identical across multiple indepen-
dent founders (compare Fig. S1 and Fig. 3). Fig. S1 is available at http://
www.jem.org/cgi/content/full/jem.20051190/DC1.
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